HRMY logo

HRMY
Harmony Biosciences Holdings Inc

17,044
Mkt Cap
$1.69B
Volume
561,357.00
52W High
$40.87
52W Low
$25.52
PE Ratio
10.67
HRMY Fundamentals
Price
$28.89
Prev Close
$29.16
Open
$29.24
50D MA
$30.64
Beta
0.83
Avg. Volume
729,626.19
EPS (Annual)
$2.71
P/B
1.92
Rev/Employee
$2.96M
$1,650.46
Loading...
Loading...
News
all
press releases
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the appointment of Peter Anastasiou as Chief Operating Officer and updates to its Board of Directors, including the appointment of...
Business Wire·9d ago
News Placeholder
More News
News Placeholder
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that Harmony's management team will participate in a fireside chat at the upcoming 25th Annual Needham Virtual Healthcare Conference...
Business Wire·11d ago
News Placeholder
Wedge Capital Management L L P NC Buys New Position in Harmony Biosciences Holdings, Inc. $HRMY
Wedge Capital Management L L P NC purchased a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the fourth quarter, according to its most recent filing...
MarketBeat·12d ago
News Placeholder
Harmony Biosciences (NASDAQ:HRMY) Stock Rating Lowered by Zacks Research
Zacks Research downgraded Harmony Biosciences from a "hold" rating to a "strong sell" rating in a report on Thursday...
MarketBeat·14d ago
News Placeholder
SG Americas Securities LLC Increases Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY
SG Americas Securities LLC grew its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 4,102.4% in the 4th quarter, according to its most recent 13F filing with...
MarketBeat·16d ago
News Placeholder
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Recommendation of "Hold" from Brokerages
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) has received an average rating of "Hold" from the twelve analysts that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, four...
MarketBeat·19d ago
News Placeholder
Are Options Traders Betting on a Big Move in Harmony Biosciences Stock?
Investors need to pay close attention to Harmony Biosciences stock based on the movements in the options market lately.
Zacks·23d ago
News Placeholder
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Update
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) saw a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling...
MarketBeat·28d ago
News Placeholder
Zuckerman Investment Group LLC Invests $3.40 Million in Harmony Biosciences Holdings, Inc. $HRMY
Zuckerman Investment Group LLC acquired a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the third quarter, according to its most recent 13F filing with...
MarketBeat·28d ago
News Placeholder
Harmony Biosciences Holdings, Inc. $HRMY Shares Sold by Nan Fung Group Holdings Ltd
Nan Fung Group Holdings Ltd cut its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 92.7% during the third quarter, according to its most recent disclosure with...
MarketBeat·28d ago
<
1
2
...
>

Latest HRMY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.